gens may result in inhibition of DNA synthesis in early Maria R.Muroni, Maddalena Frau, Giuseppina Asara, preneoplastic (3-5) and neoplastic (6) (3). This seems to depend on changes in cellular lineages Dehydroepiandrosterone (DHEA) inhibits glucose 6-phosinvolved in tumor development, with a decrease in glutathione phate dehydrogenase (G6PD) activity and growth of preneo-S-transferase (placental) (GST-P)-positive and mixed cell plastic lesions in various tissues, but its administration may lesions and an increase in amphophilic lesions, which are also enhance tumorigenesis by genotoxic carcinogens. We precursors of hepatocellular adenomas and carcinomas, which have investigated in single preneoplastic liver lesions, usually appear less malignant than those induced by Ninduced in diethylnitrosamine-initiated rats by the resistant nitrosomorpholine (8). However, long-term treatment with hepatocyte protocol, the mechanisms underlying these DHEA induces liver adenomas and carcinomas in normal rats opposite DHEA effects. Administration of DHEA (0.45% (9-11) and enhances lung (3), kidney (12), pancreas (13,14) and in the diet) for 10 and 26 weeks and of its analog 16α-fluoroliver (15-17) carcinogenesis induced by genotoxic carcinogens.
a phenotypic shift of hepatocellular carcinomas (HCCs) 1 To whom correspondence should be addressed induced by N-nitrosomorpholine to more differentiated forms Email: feo@ssmain.uniss.it (3). This seems to depend on changes in cellular lineages Dehydroepiandrosterone (DHEA) inhibits glucose 6-phosinvolved in tumor development, with a decrease in glutathione phate dehydrogenase (G6PD) activity and growth of preneo-S-transferase (placental) (GST-P)-positive and mixed cell plastic lesions in various tissues, but its administration may lesions and an increase in amphophilic lesions, which are also enhance tumorigenesis by genotoxic carcinogens. We precursors of hepatocellular adenomas and carcinomas, which have investigated in single preneoplastic liver lesions, usually appear less malignant than those induced by Ninduced in diethylnitrosamine-initiated rats by the resistant nitrosomorpholine (8). However, long-term treatment with hepatocyte protocol, the mechanisms underlying these DHEA induces liver adenomas and carcinomas in normal rats opposite DHEA effects. Administration of DHEA (0.45% (9-11) and enhances lung (3), kidney (12), pancreas (13,14) and in the diet) for 10 and 26 weeks and of its analog 16α-fluoroliver (15-17) carcinogenesis induced by genotoxic carcinogens.
5-androsten-17-one (FA, 0.25%) for 10 weeks, starting 4
The anticarcinogenic effect of DHEA has been attributed to weeks after initiation, induced an apparent decrease in the inhibition of glucose 6-phosphate dehydrogenase (G6PD), a number of glutathione S-transferase (placental) (GST-P)-rate limiting enzyme of the hexose monophosphate pathway, positive lesions and an increase in lesion volume. DHEA with a consequent decrease in liver content of ribose 5-administration for 38 weeks enhanced hepatocellular carphosphate, a nucleotide precursor (4,5), as well as decreased cinoma multiplicity. Depending on the rise in the number mevalonate biosynthesis (18) , which could result in decreased of slowly growing, remodeling GST-P-positive lesions isoprenylation of p21 RAS . However, this latter effect has only induced by DHEA and FA, overall DNA synthesis decreased been described in in vitro cells with relatively high DHEA slightly in these lesions at 14 weeks, but increased in concentrations (19) . On the other hand, production of reactive uniform lesions. Labeling index (LI) in single uniform hydroxy radicals as a consequence of (20) or independently lesions at 14 weeks ranged between very low (not different of (21, 22) peroxisome proliferation has been suggested to from normal liver) to high (>10-fold normal liver). DHEA account for the tumorigenic effect of DHEA. Reactive oxygen and FA induced broad increases in lesions with a high LI, species can stimulate cell growth during liver tumorigenesis which showed a higher number of cells overexpressing cby inducing up-regulation of the Ras/MAPK pathway (23,24), Ha-ras and/or c-fos than those with a lower LI. High G6PD c-fos and c-jun (25) (26) (27) and NF-κB (28, 29) . DHEA increases activity was inhibited by DHEA and FA in only~50% of the mutagenicity of N-nitrosobis(2-hydroxypropyl)amine and preneoplastic lesions. These data indicate selection in rats N-nitrosobis(2-hydroxypropyl)(2-oxopropyl)amine (30) and subjected to long-term DHEA and FA treatments of a can act as a complete hepatocarcinogen in rainbow trout, in subpopulation of GST-P-positive cells with high growth and which it does not induce peroxisome proliferation, even in progression potentials. Overall effects of these compounds the absence of initiating chemical carcinogens (17). The depends on the relative numbers of lesions in which genotoxicity of DHEA for this animal is strongly supported inhibition of DNA synthesis can counteract their transby the mutation of c-Ki-ras in liver tumors induced by the forming effect.
hormone. FA has been reported to be a more potent inhibitor of G6PD activity (31) and a more powerful and less toxic chemopreventive agent than DHEA (31-33). It lacks DHEA Introduction hormonal activity (32) , thus suggesting that tumor chemoprevSeveral studies have shown chemoprevention by dehydroepianention by these compounds could be attributed to a reduced drosterone (DHEA) and its synthetic analog 16α-fluoro-5-availability of pentose phosphates for DNA synthesis more androsten-17-one (FA) of tumors induced in different tissues than to hormonal activity. To our knowledge, a carcinogenic by chemicals or radiation (reviewed in 1,2). Administration of effect of FA on rat liver has not yet been studied. FA does not 0.6% DHEA in the diet to rats treated with chemical carcinoinduce liver tumors in non-initiated rainbow trout and increases HCC incidence only very slightly, without influencing multipli-DHEA-treated and FA-treated rats were killed at the end of these treatments. The body weight was measured once a week and the diet intake every day. Surviving rats (48, 45, and 38 for groups 1-3, respectively) were killed by bleeding through the abdominal aorta under ether anesthesia 14, 30 and 48 weeks after initiation. Livers were resected, cut into 2-3 mm slices and nodules with a diameter Ͼ3 mm were collected as described (7). All animals received humane care and the study protocols were in compliance with our institution's guidelines for use of laboratory animals.
Enzyme assay G6PD activity of single nodules (14 weeks after initiation) was determined at 37°C in 30 000 g supernatants of homogenates in physiological saline containing 0.66 M EDTA and 0.05% Triton X-100 as previously published (5). Data are expressed as units (U) per mg protein. One unit of enzyme activity corresponds to 1 nmol NADPH produced/min. Protein was determined according to Lowry et al. (41) using bovine serum albumin as the standard. Fig. 1 . Study design. Male F344 rats, initiated with diethylnitrosamine Isolated nodules and small pieces of liver from each lobe (of both normal rats (DENA), were fed a hyperproteic diet containing 0.02% 2-acetylaminoand rats subjected to the RH protocol) were fixed in methacarn and processed fluorene (AAF) for 2 weeks, with partial hepatectomy (PH) at the mid-point for embedding in paraffin, cut into 5 µm thick slices, dewaxed in xylene, of this feeding. Then the rats received a standard diet (group 1) or a washed with alcohol and stained with hematoxylin/eosin. Some serial slides standard diet containing 0.45% DHEA up to 38 weeks (group 2) or 0.25% were soaked, after dewaxing and washing in alcohol, in absolute methanol FA up to 14 weeks (group 3). Upward arrows represent time points at containing 0.3% hydrogen peroxide for 45 min at room temperature to remove which rats were killed for analysis.
Histology and immunohistochemistry
endogenous peroxidase activity. After rehydration in phosphate-buffered saline (PBS), the slides were microwaved for 20 min with 0.01 M sodium citrate buffer, pH 6, and then processed for GST-P immunohistochemistry as already effects may be relevant to cancer prevention, taking into DHEA and FA and attempted to correlate them with overall effects of these compounds on liver carcinogenesis.
Quantification of liver lesions
The livers were resected and the superficial gross nodules and HCCs were Materials and methods isolated. The livers were then rapidly cut into 2-3 mm slices and nodules with a diameter Ͼ1 mm were identified and counted. Morphometric analysis Animals and treatments of microscopic lesions was carried out using a Leica Quantimet 500 image Male Fisher 344 rats (160-180 g body wt at the beginning of the experiment) analyzer (Leica, Cambridge, UK). The number of lesions per cm 3 (N) and were housed individually in suspended wire-bottomed cages in a room with the mean volume of lesions (V) and the volume fraction (VF, the percentage constant temperature (22°C) and humidity (55%) and with a 12 h light (6 a.m.-of liver volume occupied by GST-P-positive lesions, calculated by the Delesse 6 p.m.) and dark (6 p.m-6 a.m.) cycle. The rats had free access to food and method) were determined according to Pugh et al. (44) . Transections with a water throughout the study. The basal diet was a standard diet, G.L.P.
radius Ͼ35 µm could be reliably identified and were included in the analysis. (Mucedola srl, Settimo Milanese, Italy). The DHEA-and FA-containing diets
Immunohistochemical analyses were performed in a blind fashion without were prepared by adding 0.45% DHEA or 0.25% FA to powdered standard knowledge of the rat group by two pathologists. The staining intensity for diet and pellets were prepared from the humidified diet, dried at 22°C and gene immunohistochemistry was scored as: not detectable, low, moderate or used within 24 h. Five untreated rats were used as a source of normal liver.
intense. The extent of staining was scored as: 0, low (Ͻ10% scattered stained The other rats were initiated with a single i.p. dose (150 mg/kg) of cells), moderate (10-50%) or high (Ͼ50%). To quantitate S phase cells 2000-diethylnitrosamine. They were subjected, 2 weeks later, to a selection treatment 5000 preneoplastic hepatocytes per liver were counted and the percentage of consisting of 15 days feeding with a hyperproteic diet containing 0.02%
GST-P-positive hepatocytes that incorporated BrdU was determined. The 2-acetylaminofluorene, with partial hepatectomy at the mid-point of this extent of DNA synthesizing cells in single lesions was scored as: 0, very low treatment (RH protocol; 40) . At the end of selection (week 4) the rats were (values in the range of normal liver values), low (up to 3-fold higher than divided into three groups (70 rats each at the beginning of the experiment;
normal liver values), moderate (3-to 10-fold higher than normal liver values) Figure 1 ). Group 1 (carcinogen-exposed control) did not receive any other or high (Ͼ10-fold normal liver values). treatment; groups 2 and 3 were fed the DHEA-or FA-containing diet, Statistical analysis respectively. The DHEA-containing diet was given for 10, 26 or 38 weeks and the FA diet for 10 weeks. The rats treated for 38 weeks with DHEA Data are expressed as means Ϯ SD. Data relative to body and liver weights, number and volume of liver lesions, remodeling and LI (total nodule averages) received standard diet for an additional 10 weeks before death. All other and G6PD activity were analyzed by ANOVA and multiple comparisons were performed by the Tukey-Kramer (TK) test. 
Results

Nodule development
Food intake did not differ and ranged between 12.5 and 13.4 g/100 g body wt/day in all rat groups, but a significant decrease in body weight occurred 10, 26 and 38 weeks after starting DHEA treatment. This treatment caused 31, 20 and 26% increases in liver weight after 10, 26 and 38 weeks, respectively (at least P Ͻ 0.05; mean values of control liver 6.96 Ϯ 1.6, 9.1 Ϯ 0.56 and 13.6 Ϯ 2.1 at 14, 30 and 48 weeks, respectively). In the rats treated for 10 weeks with FA an insignificant 10% rise in liver weight occurred.
Fourteen and 30 weeks after initiation persistent nodules were present in the liver of all rat groups. The majority of them consisted of clear/eosinophilic cell lesions larger than a liver lobule and compressing surrounding parenchyma. Figure  2 shows 38-41% decreases in nodule number/cm 3 liver at 14 weeks in rats treated with DHEA or FA with respect to carcinogen-exposed rats not treated with DHEA/FA (group 1, control). At 30 weeks the number of lesions/cm 3 decreased in all rat groups, probably as a consequence of phenotypic reversion (remodeling; see below). However, it was 45% lower in rats treated with DHEA for 26 weeks (group 2) than in the control. These changes were associated with a great rise in nodule volume, with respect to control, at both 14 and 30 weeks in rats fed DHEA and at 14 weeks in FA-treated rats. Volume fraction decreased at 14 weeks from 70% in controls to 30 and 26% in DHEA-and FA-treated rats. At 30 weeks Forty-eight weeks after initiation visible nodules (2-25 mm diameter) were present on the liver surface and in transections DNA synthesis of liver from carcinogen-exposed rats treated with DHEA Fourteen weeks after initiation LI values of GST-P-positive (groups 1 and 2). Relatively few (no more than 300/cm 3 ) lesions were~22% lower in the DHEA and FA rat groups than microscopic liver lesions were present at this time. They were in carcinogen-exposed controls (P Ͻ 0.001). DNA synthesis mostly clear/eosinophilic cell nodules in both DHEA-treated decreased by 28-31% in remodeling lesions in all rat groups. and untreated rats. Larger lesions, visible with the naked eye,
The LI of lesions with a uniform pattern (non-remodeling were in general persistent nodules (neoplastic nodules and lesions) exhibited 42.8 and 47.6% increases in the DHEA and adenomas) or well-differentiated HCCs. No differences in the FA groups, respectively, with respect to the carcinogen-exposed microscopic pattern of lesions were seen between DHEAcontrol ( Figure 3) . Thus, the overall decrease in LI in these treated and untreated rats nor were differences in tumor latter groups was largely influenced by a rise in remodeling incidence between these rat groups found, but the multiplicity lesions exhibiting relatively low DNA synthesis. The differof well-differentiated and total HCCs was significantly higher ences among groups in the LI of uniform lesions, however, in DHEA-treated than in control rats (Table I ). The increase cannot account for the 6-to 7-fold rise in lesion volume in in multiplicity of moderately differentiated HCCs was small DHEA-and FA-treated rats. The possibility was thus explored that treatments with DHEA and FA resulted in an expansion and insignificant. . Carcinogen-exposed rats without DHEA/ Total HCCs 10/10 7/7 1.5 Ϯ 0.5 3.0 Ϯ 0.4 b FA (group 1) acted as controls. The abscissa indicates the LI of each of the GST-P-positive lesions developing in a total of seven rats for the control a Diethylnitrosamine-initiated rats were treated according to the RH protocol and DHEA groups and in 14 rats for the FA group. Median values: 0.5, and then fed a standard diet or a diet containing 0.45% DHEA for 38 weeks 1.85 and 3.45 for the control, DHEA and FA groups, respectively. KS test: and then a standard diet up to death (week 48). P Ͻ 0.0001 for all groups. Dunn's test: DHEA and FA versus control, b Significantly different by TK test at P Ͻ 0.05, P Ͻ 0.01 and P Ͻ 0.001 P Ͻ 0.001; FA versus DHEA, P Ͻ 0.01. for persistent nodules, well-differentiated HCCs and total HCCs, respectively. of a subpopulation of GST-P-positive lesions with elevated and FA groups, P Ͻ 0.0001; DHEA versus FA, P Ͻ 0.01). out any appreciable difference among groups. The distribution of total lesions positive for c-fos and c-fos plus c-Ha-ras among different LI subgroups (from VL to H) did not exhibit any significant difference between carcinogen-exposed control and DHEA-treated rats (Table III) . However, the percentage of lesions with Ͼ50% positive cells (subgroup H) was constantly higher in DHEA-treated than in control rats (Table III) . The behavior of c-fos and c-Ha-ras expression in FA-treated rats ( Figure 5 ) did not differ from that of DHEA-treated rats and the results are not included in Table III . Figure 6 shows the presence of GST-P-positive lesions after initiation. G6PD activity was low or absent in some in the diet) or FA (0.25%) was started 4 weeks after initiation and was continued up to death (week 14). Carcinogen-exposed rats without DHEA/ lesions of DHEA-and FA-treated rats, which also exhibited FA (group 1) acted as controls. Note that there are at least two GST-P-positive low LI. c-fos expression was absent in these lesions and was lesions in the FA group, only one of which expressed c-fos and c-Ha-ras.
G6PD activity
instead seen in lesions with high G6PD activity (not shown).
Magnification ϫ10.
This behavior was constantly observed in several sections from six rats per treatment group. Moreover, it was confirmed was 51 and 67% in the DHEA and FA groups, against only by biochemical determination of G6PD activity in single 29% in the carcinogen-exposed controls.
isolated nodules (Figure 7 ). As expected (2,4,5), nodules Gene expression showed 2.9-fold higher G6PD activity than normal rat liver (sp. act. normal liver 48.72 Ϯ 6.31, n ϭ 4) which was partially Rapid growth of preneoplastic and neoplastic liver lesions is inhibited by DHEA and FA. However, G6PD activity in single associated with overexpression of genes related to the MAPK nodules of DHEA-and FA-treated rats exhibited greater cascade, leading to overproduction of the transcriptional factors variations than that of control rats:~50% of nodules showed c-Fos and c-Jun (45). Ras brings Raf, the first kinase of the activity in the range of that of lesions developing in rats which MAPK cascade, to the cell membrane and leads to sequential did not receive these compounds. phosphorylation of the other cascade members. Thus, expression of the c-Ha-ras and c-fos genes was studied in single liver lesions 14 weeks after initiation by immunostaining of Discussion gene products ( Figure 5 and Table III ). The analysis of 116 and 99 lesions in the carcinogen-exposed control (group 1)
Our results show a high heterogeneity of putative preneoplastic lesions induced in rat liver by the RH protocol with respect and DHEA-treated rats (group 2), respectively, showed c-fos expression in 26-28% of lesions and c-fos plus c-Ha-ras to DNA synthesis and expression of c-fos and c-Ha-ras. A good correlation between oncogene expression and LI was expression in~22 and 30% of lesions in both groups. Only one lesion from a control rat exhibited c-Ha-ras expression found: in general, the higher the number of S phase hepatocytes in each lesion, the higher the number of cells expressing c-fos without c-fos expression. Lesions positive for gene expression showed moderate/intense immunostaining for both genes, withand c-Ha-ras. The majority of lesions exhibited poor growth dimensions. Number and volume of lesions may also be influenced by an increase in liver weight secondary to hypertrophy, as well as to the presence of great amounts of nodular tissue (4,46) in the DHEA group at 14 weeks. Nonetheless, some decrease in lesion number follows stimulation of remodeling by DHEA and FA, with consequent progressive disappearance of GST-P-positive lesions (36, 47 ). An increase in the number of remodeling lesions exhibiting low DNA synthesis is probably responsible for a small decrease in LI of total liver lesions, even in the presence of stimulation of DNA synthesis in uniform lesions. It clearly appears that DHEA and treated rats. Several studies have pointed to the mechanisms of DHEA effects in carcinogenesis. Although small DHEA doses exhibit capacity coupled with phenotypic reversion, at least in some an antioxidant effect (48,49), high doses, in the range of those lesions. However, a consistent subpopulation of liver lesions used in the present study, induce production of hydroxyl (29%) was identified in which a moderate/high LI and active radicals, even in the absence of peroxisome proliferation signal transduction pathway, involving c-fos and c-Ha-ras, (21, 22) , strongly suggesting that production of reactive oxygen indicate a tendency to progress to full malignancy. species during DHEA treatment could enhance tumorigenesis Long-term treatment with DHEA and FA results in an by inducing DNA damage (45). Nonetheless, short-term treatapparent decrease in nodule number, but a marked increase in ments with DHEA inhibit cell proliferation, indicating the volume of remaining nodules. Large and coalescent liver prevalence of restraint of nucleic acid synthesis (3-5). Howlesions, especially in DHEA-and FA-treated rats, could include ever, continuous production of reactive oxygen species during or obscure smaller lesions, resulting in an underestimation of lesion number during the conversion from two to three long-term treatment in the early stages of tumorigenesis may induce accumulation of genomic damage (17,30) and activation Acknowledgements of c-Ha-ras-and c-fos-dependent signal transduction pathways In conclusion, our results indicate a mechanism of rapid 11. Metzger,C., Mayer,D., Hoffmann,H., Bocker,T., Hobe,G., Benner,A. and evolution to malignancy of preneoplastic liver lesions in 
